The U.S. Food and Drug Administration (FDA) recently granted orphan drug approval for Chrysoeriol, a cannabis-based drug used to treat acute myeloid leukaemia, which was developed by Jamaican scientist Dr. Henry Lowe.

Dr. Lowe founded Medicanja Ltd — described as “Jamaica's first medical cannabis company” — in 2013.

Its distinguished board of directors includes two former prime ministers and a former governor general.

Click here to read the complete article

GlobalVoices.org via 420Intel.com ~

Recent News Articles

Monday March 25

Greater Boston's First Pot Shop Opening Weekend Goes 'According To Plan' - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

Brookline can now be added to the short list of Massachusetts cities and towns where…

1305 hits

Monday March 25

CVS to sell CBD products in 800 stores in 8 states - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

CBD-infused sprays, roll-ons, creams and salves will be offered as an 'alternative source of relief'.

1166 hits

Monday March 25

Nearly Half of Anxiety Patients Find Medical Marijuana More Effective Than Pills - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

A new study shows that people suffering from anxiety may be able to successfully transition…

1161 hits

Monday March 25

Utah is looking for software to run its medical cannabis program - Cannabis News

in Hi-Tech

by Bruce Kennedy - Editor in Chief

The state has started its search for multimillion-dollar software that will form the spine of…

1107 hits

Tuesday March 26

Hemp About To Be Removed From Texas’ Controlled Substances List - Cannabis News

in Law & Crime

by Bruce Kennedy - Editor in Chief

The state of Texas is taking a big step toward legitimizing the use of CBD…

833 hits